TTC39A and metabolic dysfunction-associated steatohepatitis: We also analyzed the expression levels of Trem2, Anxa2, Ttc39a, and Gdf15 across various stages of the disease, including steatosis (Supplementary Figure 4A), NASH (Supplementary Figure 4B), and fibrosis (Supplementary Figure 4C).